AS
AUPH icon

Altshuler Shaham’s Aurinia Pharmaceuticals AUPH Stock Holding History

Altshuler Shaham’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.65K Sell
274
-10
-4% -$160 ﹤0.01% 377
2026
Q1 		$4.21K Buy
284
+9
+3% +$132 ﹤0.01% 302
2025
Q4 		$4.39K Buy
+275
New +$3.9K ﹤0.01% 284
2021
Q3 		– Sell
-559,412
Closed -$7.25M – 518
2021
Q2 		$7.25M Buy
559,412
+523,412
+1,454% +$6.67M 0.05% 91
2021
Q1 		$467K Buy
+36,000
New +$522K ﹤0.01% 128

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Altshuler Shaham's AUPH Position: Q2 2026 in Review

Altshuler Shaham reduced its Aurinia Pharmaceuticals (AUPH) stake by 3.5% in Q2 2026, selling an estimated $160 and leaving 274 shares worth $4.65K. The position accounts for ﹤0.01% of the portfolio, ranked #377.

Altshuler Shaham first reported a position in AUPH in Q1 2021 and has held it in 5 quarters since. The position peaked at $7.25M in Q2 2021. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Altshuler Shaham held 274 shares of Aurinia Pharmaceuticals worth $4.65K as of Q2 2026.
  • Altshuler Shaham sold 10 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $160.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Altshuler Shaham's portfolio in Q2 2026, its #377 holding.
  • Altshuler Shaham first reported a position in Aurinia Pharmaceuticals in Q1 2021 and has held it in 5 quarters since.
  • Altshuler Shaham's Aurinia Pharmaceuticals position peaked at $7.25M in Q2 2021.
  • 283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Altshuler Shaham's 13F filing for Q2 2026, filed 12 Aug 2026.